- illustrations
- The Human Brain's Brodmann Area 52 In Lateral View
The Human Brain's Brodmann Area 52 In Lateral View
A lateral view of Brodmann area 52, the parainsular zone at the junction of the temporal lobe and insula.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Sweeping across a lateral cerebral hemisphere, the animation localizes Brodmann area 52 along the superior temporal plane where the temporal operculum meets the insular cortex at the circular sulcus. The parainsular cortex is framed by the superior temporal gyrus laterally and the insula medially, with the posterior limit approaching the temporoparietal junction and the anterior portion trending toward the limen insulae. As the sequence progresses, sulcal and gyral boundaries sharpen to orient area 52 relative to the lateral (Sylvian) fissure, adjacent opercula, and the superior temporal sulcus. A tight region. Easy to misplace. Area 52 matters because it sits at a convergence point for auditory association cortex and insular networks, a neighborhood often implicated in clinical localization of seizures, language-related auditory processing, and peri-insular surgical corridors. The animated lateral approach clarifies why this parcel is hard to teach from static plates: small shifts in the apparent depth of the Sylvian fissure and the overhang of the temporal operculum change what you can reasonably label as parainsular cortex. For neurosurgical planning, that moving perspective helps clinicians discuss how an opercular trajectory can expose insular and peri-insular cortex while keeping orientation to the superior temporal gyrus. Use this clip to support neuroanatomy lectures on Brodmann parcellations, to illustrate peri-Sylvian cortical topography in epilepsy conference slides, or as a labeling reference for atlases and educational modules that distinguish temporal operculum from true insula in lateral view. Anatomical accuracy verified by SciePro's Medical Advisory Board.